Healthcare conglomerate CVS Well being Company (NYSE: CVS) on Wednesday introduced third-quarter 2024 outcomes, reporting a lower in adjusted earnings and a rise in revenues. The highest line exceeded estimates.
September-quarter adjusted revenue decreased 51% year-over-year to $1.09 per share and missed analysts’ estimates. On a reported foundation, web earnings was $87 million or $0.07 per share in Q3, in comparison with $2.26 billion or $1.75 per share within the prior-year quarter.
In the meantime, revenues elevated 6% year-over-year to $95.4 billion throughout the three months and topped expectations. Whole same-store gross sales climbed 15.5% year-over-year.
“My commitment to our CVS Health colleagues and our customers is to drive focused execution of our integrated strategy to improve the health of the 185 million people we are privileged to serve.,” stated CVS CEO David Joyner.
